Find Bpc-157 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Bpc-157, 137525-51-0, Bpc 157, Bepecin, Bpc 15, Pl-10
Molecular Formula
C62H98N16O22
Molecular Weight
1419.5  g/mol
InChI Key
HEEWEZGQMLZMFE-RKGINYAYSA-N
FDA UNII
8ED8NXK95P

Bpc-157
Bepecin is under investigation in clinical trial NCT02637284 (PCO-02 - Safety and Pharmacokinetics Trial).
1 2D Structure

Bpc-157

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid
2.1.2 InChI
InChI=1S/C62H98N16O22/c1-31(2)25-37(55(92)74-50(32(3)4)62(99)100)71-46(81)29-65-51(88)33(5)67-53(90)38(26-48(84)85)73-54(91)39(27-49(86)87)72-52(89)34(6)68-57(94)41-15-10-21-75(41)58(95)35(13-7-8-20-63)70-45(80)30-66-56(93)40-14-9-22-76(40)60(97)43-17-12-24-78(43)61(98)42-16-11-23-77(42)59(96)36(18-19-47(82)83)69-44(79)28-64/h31-43,50H,7-30,63-64H2,1-6H3,(H,65,88)(H,66,93)(H,67,90)(H,68,94)(H,69,79)(H,70,80)(H,71,81)(H,72,89)(H,73,91)(H,74,92)(H,82,83)(H,84,85)(H,86,87)(H,99,100)/t33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,50-/m0/s1
2.1.3 InChI Key
HEEWEZGQMLZMFE-RKGINYAYSA-N
2.1.4 Canonical SMILES
CC(C)CC(C(=O)NC(C(C)C)C(=O)O)NC(=O)CNC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CCCCN)NC(=O)CNC(=O)C2CCCN2C(=O)C3CCCN3C(=O)C4CCCN4C(=O)C(CCC(=O)O)NC(=O)CN
2.1.5 Isomeric SMILES
C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]3CCCN3C(=O)[C@@H]4CCCN4C(=O)[C@H](CCC(=O)O)NC(=O)CN
2.2 Other Identifiers
2.2.1 UNII
8ED8NXK95P
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Booly Protection Compound 15

2. Bpc 15

3. Bpc 157

4. Bpc-15

5. Bpc-157

2.3.2 Depositor-Supplied Synonyms

1. Bpc-157

2. 137525-51-0

3. Bpc 157

4. Bepecin

5. Bpc 15

6. Pl-10

7. 8ed8nxk95p

8. Booly Protection Compound 15

9. Pld-116

10. Pl-14736

11. Gly-glu-pro-pro-pro-gly-lys-pro-ala-asp-asp-ala-gly-leu-val

12. Bpc157

13. Bpc15

14. Unii-8ed8nxk95p

15. Bpc-15

16. Chembl4297358

17. Ex-a4283

18. Mfcd06407962

19. Db11882

20. Bs-14984

21. D84081

22. Q27270252

23. Gastric Juice Peptide Fragment Trifluoroacetate (bpc 157) (h-gly-l-glu-l-pro-l-pro-l-pro-gly-l-lys-l-pro-l-ala-l-asp-l-asp-l-ala-gly-l-leu-l-val-oh)

24. L-valine, Glycyl-l-.alpha.-glutamyl-l-prolyl-l-prolyl-l-prolylglycyl-l-lysyl-l-prolyl-l-alanyl-l-.alpha.-aspartyl-l-.alpha.-aspartyl-l-alanylglycyl-l-leucyl-

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 1419.5 g/mol
Molecular Formula C62H98N16O22
XLogP3-9
Hydrogen Bond Donor Count16
Hydrogen Bond Acceptor Count24
Rotatable Bond Count39
Exact Mass1418.70415882 g/mol
Monoisotopic Mass1418.70415882 g/mol
Topological Polar Surface Area574 Ų
Heavy Atom Count100
Formal Charge0
Complexity3040
Isotope Atom Count0
Defined Atom Stereocenter Count12
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Ulcer Agents

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)


ABOUT THIS PAGE

Looking for 137525-51-0 / Bpc-157 API manufacturers, exporters & distributors?

Bpc-157 manufacturers, exporters & distributors 1

79

PharmaCompass offers a list of Bpc-157 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bpc-157 manufacturer or Bpc-157 supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bpc-157 manufacturer or Bpc-157 supplier.

PharmaCompass also assists you with knowing the Bpc-157 API Price utilized in the formulation of products. Bpc-157 API Price is not always fixed or binding as the Bpc-157 Price is obtained through a variety of data sources. The Bpc-157 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Bpc-157

Synonyms

137525-51-0, Bpc 157, Bepecin, Bpc 15, Pl-10, 8ed8nxk95p

Cas Number

137525-51-0

Unique Ingredient Identifier (UNII)

8ED8NXK95P

About Bpc-157

Bepecin is under investigation in clinical trial NCT02637284 (PCO-02 - Safety and Pharmacokinetics Trial).

Bpc 157 Manufacturers

A Bpc 157 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bpc 157, including repackagers and relabelers. The FDA regulates Bpc 157 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bpc 157 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Bpc 157 Suppliers

A Bpc 157 supplier is an individual or a company that provides Bpc 157 active pharmaceutical ingredient (API) or Bpc 157 finished formulations upon request. The Bpc 157 suppliers may include Bpc 157 API manufacturers, exporters, distributors and traders.

click here to find a list of Bpc 157 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Bpc 157 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bpc 157 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Bpc 157 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Bpc 157 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Bpc 157 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bpc 157 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Bpc 157 suppliers with NDC on PharmaCompass.

Bpc 157 GMP

Bpc 157 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Bpc 157 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bpc 157 GMP manufacturer or Bpc 157 GMP API supplier for your needs.

Bpc 157 CoA

A Bpc 157 CoA (Certificate of Analysis) is a formal document that attests to Bpc 157's compliance with Bpc 157 specifications and serves as a tool for batch-level quality control.

Bpc 157 CoA mostly includes findings from lab analyses of a specific batch. For each Bpc 157 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Bpc 157 may be tested according to a variety of international standards, such as European Pharmacopoeia (Bpc 157 EP), Bpc 157 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bpc 157 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty